Multiple targeted therapies: is there a place for Vach type-3 or type-4 design trials. [electronic resource]
- Biometrical journal. Biometrische Zeitschrift Dec 2006
- 911-3; discussion 914-5 p. digital
Publication Type: Comment; Journal Article
0323-3847
10.1002/bimj.200610298 doi
Antineoplastic Agents--therapeutic use Biometry--methods Clinical Trials, Phase III as Topic--methods Data Interpretation, Statistical Drug Delivery Systems--methods Humans Neoplasms--drug therapy Patient Selection Research Design